MedPath

Tacrolimus

TACROLIMUS OINTMENT 0.03% TACROLIMUS OINTMENT 0.1%

Approved
Approval ID

de81b7df-a4d6-431f-8ec4-06755a417da8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2023

Manufacturers
FDA

Mayne Pharma Inc.

DUNS: 867220261

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tacrolimus

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68308-703
Application NumberANDA200744
Product Classification
M
Marketing Category
C73584
G
Generic Name
tacrolimus
Product Specifications
Route of AdministrationTOPICAL
Effective DateNovember 1, 2021
FDA Product Classification

INGREDIENTS (6)

mineral oilInactive
Code: T5L8T28FGP
Classification: IACT
tacrolimusActive
Quantity: 1 mg in 1 g
Code: WM0HAQ4WNM
Classification: ACTIM
propylene carbonateInactive
Code: 8D08K3S51E
Classification: IACT
petrolatumInactive
Code: 4T6H12BN9U
Classification: IACT
paraffinInactive
Code: I9O0E3H2ZE
Classification: IACT
white waxInactive
Code: 7G1J5DA97F
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.